Home

West Pharmaceutical Services, Inc. Common Stock (WST)

221.50
+1.34 (0.61%)
NYSE · Last Trade: Apr 2nd, 7:35 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
How Is The Market Feeling About West Pharmaceutical Servs?benzinga.com
Via Benzinga · March 28, 2025
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.
Via StockStory · March 25, 2025
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · March 18, 2025
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)
Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.
Via StockStory · March 18, 2025
Why NYSE:WST is a Top Pick for Dividend Investors.chartmill.com
Analyzing WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s Dividend Potential.
Via Chartmill · February 18, 2025
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks, starting with UFP Technologies (NASDAQ:UFPT).
Via StockStory · March 13, 2025
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers.
Via StockStory · March 12, 2025
Florida Rep. Jared Moskowitz Sold Up to $15K Worth of West Pharmaceutical Servs Stockbenzinga.com
Via Benzinga · March 7, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 28, 2025
Friday's session: top gainers and losers in the S&P500 indexchartmill.com
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Via Chartmill · February 28, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 24, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · February 24, 2025
10 Worst Performing Large-Caps Last 12 Monthstalkmarkets.com
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via Talk Markets · February 23, 2025
Discover which S&P500 stocks are making waves on Friday.chartmill.com
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 21, 2025
Top 2 Health Care Stocks That May Rocket Higher This Monthbenzinga.com
Via Benzinga · February 21, 2025
Stay informed with the top movers within the S&P500 index on Tuesday.chartmill.com
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 18, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · February 18, 2025
Wall Street Bounces Back: Top-Performing ETFs Of Last Weekbenzinga.com
Wall Street rebounds after losing streak; S&P 500 closes 0.07% below record high. Global trade developments influence market direction.
Via Benzinga · February 18, 2025
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?benzinga.com
Eleven large-cap stocks performed poorly in the last week. West Pharmaceutical, The Trade Desk, Fidelity National, and others saw significant declines.
Via Benzinga · February 16, 2025
What's going on in today's session: S&P500 moverschartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via Chartmill · February 14, 2025
In today's session, there are S&P500 stocks with remarkable trading volume.chartmill.com
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · February 14, 2025
Discover which S&P500 stocks are making waves on Friday.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 14, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · February 14, 2025
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · February 14, 2025
Why West Pharmaceutical Services (WST) Stock Is Nosediving
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year revenue and earnings guidance fell short of Wall Street's estimates. Adjusted EPS declined slightly y/y, reflecting margin pressures and a less favorable product mix. These factors contributed to the lower-than-expected full-year EPS guidance. 
Via StockStory · February 13, 2025